ASPIRIN FOR MYOCARDIAL-INFARCTION - CLINICAL PHARMACOKINETIC CONSIDERATIONS

被引：15

作者：

BOCHNER, F

LLOYD, JV

机构：

[1] ROYAL ADELAIDE HOSP, DEPT CLIN PHARMACOL, ADELAIDE, SA 5000, AUSTRALIA

[2] UNIV ADELAIDE, INST MED & VET SCI, DIV HAEMATOL, ADELAIDE, SA, AUSTRALIA

来源：

CLINICAL PHARMACOKINETICS | 1995年 / 28卷 / 06期

关键词：

D O I：

10.2165/00003088-199528060-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：433 / 438

页数：6

共 44 条

[1] PLASMA ACETYLSALICYLATE AND SALICYLATE AND PLATELET CYCLOOXYGENASE ACTIVITY FOLLOWING PLAIN AND ENTERIC-COATED ASPIRIN [J].

ALI, M ;

MCDONALD, JWD ;

THIESSEN, JJ ;

COATES, PE .

STROKE, 1980, 11 (01) :9-13

[2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[3]

[Anonymous], 1988, LANCET, V2, P349

[4]

[Anonymous], 1988, BRIT MED J, V296, P320

[5]

BASINSKI A, 1988, LANCET, V2, P1188

[6] ASPIRIN AND FIBRINOLYSIS IN ACUTE MYOCARDIAL-INFARCTION - META-ANALYTIC EVIDENCE FOR SYNERGY [J].

BASINSKI, A ;

NAYLOR, CD .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (10) :1085-1096

[7] ADJUVANT ANTIPLATELET STRATEGIES IN CORONARY THROMBOLYSIS [J].

BECKER, RC ;

GORE, JM .

CIRCULATION, 1991, 83 (03) :1115-1117

[8]

BOCHNER F, 1989, THROMB HAEMOSTASIS, V61, P211

[9] BIOINEQUIVALENCE OF 4 100MG ORAL ASPIRIN FORMULATIONS IN HEALTHY-VOLUNTEERS [J].

BOCHNER, F ;

SOMOGYI, AA ;

WILSON, KM .

CLINICAL PHARMACOKINETICS, 1991, 21 (05) :394-399

[10] PHARMACOKINETICS OF LOW-DOSE ORAL MODIFIED RELEASE, SOLUBLE AND INTRAVENOUS ASPIRIN IN MAN, AND EFFECTS ON PLATELET-FUNCTION [J].

BOCHNER, F ;

WILLIAMS, DB ;

MORRIS, PMA ;

SIEBERT, DM ;

LLOYD, JV .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (03) :287-294

← 1 2 3 4 5 →